Final Exam Flashcards

1
Q

What are the two main causes of chromosome abnormalities?

A
  • Altering the concentration of gene products (dupliate/amplify or delete/interrupt)
  • Altering the gene product itself (fuse regulatory regions or fuse functions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why does the BCR/ABL1 translocation cause CML?

A
  • The ABL1 tyrosine kinase produced by the fusion is permanently turned on, activates signal pathways
  • Leads to malignant transformation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What diagonstic assays can be used to identify the t(9;22) translocation (BRC/ABL1)?

A
  • Karyotyping (long 9 and short 22)
  • BCR-ABL1 dual color dual fusion assay (FISH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does Imatinib (and other TKIs) work to cause remission in CML?

A
  • Blocks the ATP binding center of BCR-ABL1 kinase
  • This block phosphorylation of proteins
  • No more uncrontolled growth and cell signaling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How should CML patients be treated when they have blast crisis with first-line TKI or no response to second TKI?

A

BM/SC Transplantation (only true cure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is CML and some other diseases monitored?

A
  • Use of Interphase FISH assay & karyotyping
  • Interphase FISH looks at many cells when they are not actively dividing
  • Look for abnormal cells (co-localization of BCR/ABL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the benefits of karyotype monitoring in disease progression over FISH?

A
  • Can detect new chromosome abnormalities that arise
  • This tells you if the disease is getting worse or remaining in remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a common chromosomal abnormality with AML?

A
  • MLL (KMT2A) gene
  • Also known as 11q23.3 (location)
  • Also known as t(4;11) translocation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the difference between dual fusion FISH and break apart FISH?

A
  • Dual Fusion: Co-localization tells you that there is an abnormality (translocation causes 2 known gene regions to be in same area)
  • Break Apart: Co-localization is normal, abnormality is when the 5’3’ region of a gene is no longer in same area (use when there are many gene partners for a translocation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is one of the limitation of break apart FISH?

A

It does not tell you what the partner chromsome/locus is in the translocation, just that an abnormality has occured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the limitation of chromsome microarray?

A
  • Balanced rearrangements (no gain or loss present)
  • Low level mosaicism/clonal evolution (minimal residual disease, minor clones, less than 10-15%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some of the benefits of chromosome microarray?

A
  • Can detect cytogenetic abnormalities missed by traditional cytogenetics
  • Rearrangements below level of G-band detection (really small deletions!)
  • Copy number neutral loss of heterozygosity or acquired homozygosity (SNP microarray)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a common finding in all types of leukemia?

A

Copy number neutral loss of heterozygosity or acquired homozygosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 4 key fungal cell structures?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between septate and aseptate hyphae?

A
  • Spetate have clear cell walls
  • Aspetate get longer without clear divisions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What kind of infections are encapsulated fungi associated with?

A

Often associated with meningitis due to CNS infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is an important structure formed by yeast (particularly candida)?

A
  • A germ-tube (outgrowth produced by spores of spore-releasing fungi during germination)
  • Creates somatic hyphae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a dimorphic fungus?

A

Converts between yeast and hyphae

19
Q

What arm of adaptive immunity is important for fungal infections?

A
  • Fungal infections occur with impaired cell-mediated immunity (AIDS/HIV)
  • So, you need T cells!
  • Humoral immunity is not so much needed (B cells)
20
Q

What fungi is this?

21
Q

What fungi is this?

A

Cryptococcus

22
Q

What fungi is this?

A

Aspergillus

23
Q

What fungi is this?

A

Mucor & Rhizopus

24
Q

What fungi is this?

25
Q

What are some risk factors for fungal infections?

A
  • Neutropenia (or dysfunction)
  • HIV/AIDS
  • T cell deficency
  • Transplantation
  • Immunosuppressive Therapy
  • Antibacterial Therapy
  • Uncontrolled Diabetes
26
Q

What is the target of the following antifungal agents?

  • Polyenes
  • Azoles
  • Echinocandins
  • Pyrimidine Analogues
A
  • Polyenes- ergosterol (forms pores in membrane)
  • Azoles- inhibits ergosterol synthesis
  • Echinocandins- inhibits beta-glucan synthesis
  • Pyrimidine Analogues- inhibits fungal thymidine synthesis
27
Q

What are the uses of the following antifungal agents?

  • Polyenes
  • Azoles
  • Echinocandins
  • Pyrimidine Analogues
A
  • Polyenes- broad spectrum
  • Azoles- broad spectrum
  • Echinocandins- yeast and molds (not dimorphics)
  • Pyrimidine Analogues- yeasts only (often with resistance)
28
Q

What are some examples of the following antifungal agents?

  • Polyenes
  • Azoles
  • Echinocandins
  • Pyrimidine Analogues
A
  • Polyenes- amphotereicin B, nyastatin
  • Azoles- anything ending with -azole
  • Echinocandins- anything ending with -fungin
  • Pyrimidine Analogues- 5-FC
29
Q

What chemotherapeutic agent is associated with pulmonary toxicity?

A
  • Bleomycin
  • Cuases stimulation of lung fibroblasts leading to fibrosis
  • Also hypersensitivity pneumonitis
30
Q

What is the action of most breast cancer chemotherapies?

A
  • Anti-estrogens (Tamoxifen)
  • Aromatase inhibitors (Anastrazole)
31
Q

What is the action of most prostate cancer chemotherapies?

A
  • All work to decrease testosterone or its effects
  • Antiandrogens (Flutamide)
  • LHRH agonists (Leuprolide)
  • GnRH antagonists
  • CYP17 inhibitors
32
Q

What are the 4 monoclonal antibodies and targets you need to know?

A
  • Rituximab, CD20, lymphoma
  • Trastuzumab, Her-2, breast cancer
  • Cetuximab, EGFR, solid tumors
  • Bevacizumab, VEGF, solid tumors
33
Q

What are some symptoms of Bevacizumab and cetuximab?

A
  • Bevacizumab- proteinuria, GI perforation, hypertension
  • Cetuximab- severe hypersensitivity (chimeric) and acneiform rash (increased survival)
34
Q

What are 3 immunotherapy agents used in cancer to reactivate T cells?

A
  • Ipilimumab- Anti CTLA4
  • Pembrolizumab- Anti PD1
  • Nivolumab- Anti PD1
35
Q

What is responsible for the acute clinical symptoms in acute lytic viral infections?

A
  • Tissue destruction due to virus replication
  • Side effects of host immune response
36
Q

What are some main differences between acute and chronic lytic viral infections??

A
  • Acute- short time course (3-14d), lysis of infected cell with progeny production
  • Chronic- continual infection/re-infection cycle, does not result in cell lysis
37
Q

What are some characteristics of viral nucleic acid during latency?

A
  • Both RNA and DNA viruses can establish latency
  • All latent viruses maintain genome as DNA
  • Genome can be integrated (provirus)
  • Genome can be extrachromosomal (episome)
38
Q

What is the site of latency for EBV and CMV?

A
  • EBV- lymphoid cells
  • CMV- various cells
39
Q

How does EBV infect?

A
  • Infects B cells via CD21 complement receptor
  • Results in atypical lymphocytes
  • Production of heterophile antibodies
40
Q

What are some EBV associated diseases?

A
  • Life-threatening in X-linked lymphoproliferative syndrome
  • Hairy Leukoplakia in immunocompromised
  • Burkitt’s lymphoma (HIV associated)
41
Q

How does EBV transform in the body?

A
  • Latency via episomal DNA in B cells
  • Increases IL-10 (more proliferation)
42
Q

What is a significant marker of CMV?

A

Owl eyes or aliens around mucosal areas

43
Q

How does CMV establish latency?

A

Unstable MHC-1 in infected cells, so can’t be recognized by CD8+ T cells

44
Q

What are some clinical findings with CMV?

A
  • “Blueberry muffin” lesions
  • Heterophile-negative mono
  • Risks in transplant patients
  • Infections in AIDS patients